RTHK came to C2i to ask Dr Michael Chan questions about his recent breakthrough study on Simeprevir as a potent treatment for COVID19.
Interview of Michael Chan for RTHK
top of page
bottom of page
RTHK came to C2i to ask Dr Michael Chan questions about his recent breakthrough study on Simeprevir as a potent treatment for COVID19.
Comments